Brain natriuretic peptide (BNP) as a biomarker of myocardial ischemia-reperfusion injury in cardiac transplantation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Cardiothoracic and Vascular Anesthesia

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.jvca.2010.05.008PMID 20655247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008.

  2008cited by this paper
• Natriuretic peptide testing in emergency settings

  2008cited by this paper
• Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials.

  2007cited by this paper
• Prolonged cardiac allograft ischemic time – no impact on long‐term survival but at what cost?

  2007cited by this paper
• Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds?

  2007cited by this paper
• Biomarkers after heart transplantation: nongenomic.

  2007cited by this paper
• Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality*

  2006cited by this paper
• Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart Transplantation: More Than a Hemodynamic Marker

  2006cited by this paper
• B-type natriuretic peptide to assess haemodynamic status after cardiac surgery.

  2006cited by this paper
• Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery

  2006cited by this paper
• Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting*

  2005cited by this paper
• Brain natriuretic peptide release in cardiac surgery patients.

  2005cited by this paper
• Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

  2005cited by this paper
• Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

  2005cited by this paper
• Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.

  2005cited by this paper
• Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements.

  2005cited by this paper
• Early mortality after cardiac transplantation: should we do better?

  2005cited by this paper
• Early institution of mechanical support improves outcomes in primary cardiac allograft failure.

  2005cited by this paper
• The challenge of improving donor heart preservation.

  2004cited by this paper
• A-Type and B-Type Natriuretic Peptides in Cardiac Surgical Procedures

  2004cited by this paper
• Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics.

  2004cited by this paper
• Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance.

  2004cited by this paper
• Myocardial and endothelial protection for heart transplantation in the new millenium: lessons learned and future directions.

  2004cited by this paper
• Off-pump CABG attenuates myocardial enzyme leakage but not postoperative brain natriuretic peptide secretion.

  2002cited by this paper
• VALUE OF CARDIAC TROPONIN I AND T FOR SELECTION OF HEART DONORS AND AS PREDICTORS OF EARLY GRAFT FAILURE 1

  2001cited by this paper
• Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest.

  2001cited by this paper
• Mechanisms of postischemic contractile dysfunction.

  1999cited by this paper
• Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest.

  1997cited by this paper
• Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation.

  1994cited by this paper
• Donor and recipient determinants of fatal and nonfatal cardiac dysfunction during the first week after orthotopic heart transplantation.

  1992cited by this paper
• Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells.

  1992cited by this paper
• Brain death: physiologic definitions.

  1985cited by this paper

• Heart Transplantation: Immunological Challenges Revisited.

  2025cites this paper
• Design and synthesis of matrine derivatives for anti myocardial ischemia-reperfusion injury by promoting angiogenesis.

  2024cites this paper
• Heart transplantation and biomarkers: a review about their usefulness in clinical practice

  2024cites this paper
• The correlation of cardiac biomarkers and myocardial iron overload based on T2* MRI in major beta-thalassemia

  2021cites this paper
• Peptide–Peptide Co-Assembly: A Design Strategy for Functional Detection of C-peptide, A Biomarker of Diabetic Neuropathy

  2020cites this paper
• An overview of different methods of myocardial protection currently employed peri-transplantation

  2017cites this paper
• NT-pro-BNP como marcador de obstrucción microvascular y de riesgo elevado en pacientes llevados a angioplastia primaria NT-pro-BNP as a predictor of microvascular obstruction and high risk among patients taken to primary PCI

  2016cites this paper
• B‐type natriuretic peptide trends after pediatric heart transplantation

  2014cites this paper
• Primary Graft Dysfunction After Heart Transplantation

  2014cites this paper
• Perioperative Myocardial Injury after Adult Heart Transplant: Determinants and Prognostic Value

  2013cites this paper
• Early Graft Failure After Heart Transplantation: Prevention and Treatment

  2012cites this paper
• Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

  2011cites this paper
• The year in cardiothoracic and vascular anesthesia: selected highlights from 2010.

  2011cites this paper
• Publications - Journal Articles

  2010cites this paper